Home BioGenCell

BioGenCell

In operation
Seed Round Financing
Developer of Microvascular Disease Treatment Platform
Basic
Enterprise Profile

Basic Information

BioGenCell's mission is to develop its innovative technology platform, using highly standardized therapies derived from adult stem cells, to rapidly create easy-to-use, patient-friendly, and cost-effective treatments for various degenerative and life-threatening vascular diseases.
BioGenCell Limited
Israel
less than 15 people
January 01, 2008
info@biogencell.net

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Cardiovascular Disease
Application Scenarios
Innovative Drugs